Dashboard
With a growth in Net Sales of 2187.32%, the company declared Very Positive results in Jun 25
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD -103.21 MM
- ROCE(HY) Highest at -65.3%
- RAW MATERIAL COST(Y) Fallen by -22.12% (YoY)
Rising Promoter Confidence
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
USD 394 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.63
-86.31%
3.04
Total Returns (Price + Dividend) 
Lexicon Pharmaceuticals, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Lexicon Pharmaceuticals, Inc. technically bullish or bearish?
As of 31 October 2025, the technical trend for Lexicon Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current stance is bullish with a strong daily moving average signal supporting this view. The weekly MACD is also bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a mildly bullish trend in both weekly and monthly time frames. However, the KST shows a mildly bearish signal on the weekly chart, which slightly tempers the overall bullish sentiment. In terms of performance, Lexicon Pharmaceuticals has delivered an impressive year-to-date return of 80.09%, significantly outperforming the S&P 500's 16.30% over the same period. However, over longer periods, such as 3 years, the stock has underperformed with a return of -37.85% compared to the S&P 500's 76.66%. Overall, the current technical indicators suggest a bullish stance, albeit with some mixed signals in th...
Read MoreIs Lexicon Pharmaceuticals, Inc. technically bullish or bearish?
As of 31 October 2025, the technical trend for Lexicon Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages also indicate a bullish stance. Bollinger Bands show a mildly bullish trend on the weekly chart and a bullish trend on the monthly chart. However, the KST and OBV indicators present mixed signals, with the weekly KST being mildly bearish and the weekly OBV also mildly bearish, while both are mildly bullish on the monthly timeframe. In terms of performance, Lexicon Pharmaceuticals has significantly outperformed the S&P 500 year-to-date with an 84.16% return compared to the S&P 500's 16.30%, but has underperformed over the 1-year and 3-year periods. Overall, the current technical stance is bullish, supported by strong moving averages and Bollinger Bands, despite some mixed signals from other in...
Read MoreIs Lexicon Pharmaceuticals, Inc. technically bullish or bearish?
As of 31 October 2025, the technical trend for Lexicon Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The daily moving averages are also bullish, supporting the overall bullish stance. The Bollinger Bands show a mildly bullish signal on the weekly chart and a bullish signal on the monthly chart. However, the KST and OBV indicators present mixed signals, with KST being mildly bearish on the weekly and mildly bullish on the monthly, and OBV showing mild bearishness weekly but bullishness monthly. Overall, the strength of the bullish trend is reinforced by the daily moving averages and the monthly Bollinger Bands. There is no available return data for comparison with the S&P 500....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2025
Shareholding Compare (%holding) 
Strategic Entities
Held in 27 Schemes (18.09%)
Held by 67 Foreign Institutions (40.06%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 2,123.08% vs -95.11% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 113.04% vs 25.15% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 2,491.67% vs 1,100.00% in Dec 2023
YoY Growth in year ended Dec 2024 is -13.16% vs -73.80% in Dec 2023






